IRS1 and Alzheimer disease: The meta-analysis results of p-Y-IRS-1 showed that patients with AD had no significant differences in the protein levels compared with the controls (SMD = −2.397, 95% CI: −5.258 to 0.463, p = 0.101) (Figure 3C).